AI assistant
Sending…
ACADIA PHARMACEUTICALS INC — Director's Dealing 2017
May 17, 2017
31237_dirs_2017-05-17_53d0275b-4ea9-4f17-bde3-c8e9791dc259.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2017-05-15
Reporting Person: Baity Glenn (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-15 | Common Stock | M | 14093 | $1.62 | Acquired | 81156 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-15 | Stock Option (right to buy) | $1.62 | M | 14093 | Disposed | 2021-03-24 | Common Stock (14093) | Direct |
Footnotes
F1: 25% of the shares subject to the Stock Option vested and became exercisable on March 25, 2012. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
More from ACADIA PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Director's Dealing
2026
Mar 20